Develops small molecule drugs that block secretion and trigger degradation of harmful proteins to prevent and treat disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Gate Bioscience is developing Molecular Gates, a new class of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin inside cells, thereby preventing them from causing disease. Their proprietary platform enables the discovery of these drugs, which work by blocking disease-causing proteins from being secreted, leading to their degradation and potential disease elimination.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Gate Bioscience Management Team
Investors
Andreessen Horowitz
ARCH Venture Partners
Google Ventures
Versant Ventures, Inc.
Gate Bioscience Valuations & Financials
View real-time NPM data on Gate Bioscience stock including daily Gate Bioscience stock price estimates, valuation history, and historical share price information. Access Gate Bioscience financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Gate Bioscience pricing across six independent market signals. Looking for private company due diligence data sources on Gate Bioscience? Get in touch to learn more.
Similar Companies
like Gate Bioscience
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
NFT Genius
Web3 & Digital Assets
A blockchain development firm that offers secure and efficient decentralized finance applications.
Checkly
Unifies testing, monitoring, and observability for web apps and APIs with code-driven workflows integrated into DevOps pipelines.
CodaMetrix
Healthcare & Life Sciences
An AI-driven company that automates medical coding to enhance efficiency and accuracy in healthcare revenue management.
Stratyfy
Delivers transparent AI solutions for financial institutions to automate risk, detect fraud, and reduce bias in decision-making.
Eaglebrook Advisors
FinTech
Platform enabling wealth managers to manage tax-optimized cryptocurrency portfolios through separate managed accounts with secure custody solutions.
Pocket7Games
Offers skill-based mobile games where players compete in quick matches for prizes across cards, bingo, sports, and puzzles.
Found
Healthcare & Life Sciences
Digital health platform provides personalized weight loss programs combining prescription medications, clinician support, and health coaching.
Peach
Provides a configurable cloud-based loan servicing platform to streamline compliance management and borrower communications for credit providers.
FAQ
We have answers
Gate Bioscience stock does not trade on public stock exchanges. Gate Bioscience stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Gate Bioscience stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Gate Bioscience Stock does not trade on public stock exchanges. In order to sell Gate Bioscience shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Gate Bioscience does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Gate Bioscience share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Gate Bioscience stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Gate Bioscience stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Gate Bioscience stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Gate Bioscience is a private company and has not had an IPO. There is currently no Gate Bioscience IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Gate Bioscience IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
